Acadian Asset Management LLC Chembio Diagnostics, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$3.28 - $5.93 $303,075 - $547,937	-92,401 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$3.18 - $15.54 $293,835 - $1.44 Million	92,401 New	92,401 $300,000
Q4 2018 Feb 07, 2019	SELL	$4.95 - $10.5 $39,436 - $83,653	-7,967 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$7.8 - $11.1 $31,847 - $45,321	4,083 Added 105.12%	7,967 $88,000
Q1 2018 Apr 12, 2018	BUY	$7.05 - $9.0 $27,382 - $34,956	3,884 New	3,884 $31,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.